|Day's Range||77.39 - 78.91|
|52 Week Range||57.68 - 96.38|
|PE Ratio (TTM)||-99.31|
|Earnings Date||May 2, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||91.53|
Apple may be exploring ways to monitor glucose levels, but Alphabet's efforts show it's a tough slog.
Dexcom Inc. (DXCM), a San Diego-based manufacturer of continuous glucose monitoring for patients with diabetes, has expanded into a new manufacturing facility in Mesa. The 180,000-square-foot facility will support the company's global manufacturing operations and is projected to create more than 500 jobs over the next several years. A ribbon-cutting ceremony is scheduled for April 25 at the new facility, 232 S. Dobson Road, Mesa, which is its second manufacturing plant.
Medtronic's MiniMed 670G could reduce the burden on Type 1 diabetes patients, as well as slow diabetes progression by keeping blood glucose levels on target.